Safety Alerts

MHRA Class 4 Medicines Defect Notification: Co-Amoxiclav powder for oral suspension 250/62.5 mg/ml (Sandoz Limited)

Published
Source
PSNC Dispensing & Supply News
Imported
5 Nov 2026

MHRA Class 4 Medicines Defect Notification: Co-Amoxiclav powder for oral suspension 250/62.5 mg/ml (Sandoz Limited) Drug alert number: EL(26)A/46 Date issued: 05 November 2026 Sandoz Limited have informed the MHRA of errors in the dosing table in the Summary of Product Characteristics (SmPC) for Co-amoxiclav 250/62.5 mg/5 ml Powder for Oral Suspension. DMRC reference number: DMRC- [...]

The post MHRA Class 4 Medicines Defect Notification: Co-Amoxiclav powder for oral suspension 250/62.5 mg/ml (Sandoz Limited) appeared first on Community Pharmacy England.

View original alert (opens in a new tab)

Important: This alert is gathered automatically for information only. Always refer to the original source and follow your practice’s own clinical governance procedures.

The weekly digest lists every alert published in a week, grouped by source. View the weekly digest

Back to Safety Alerts